neo-gambogic acid has been researched along with xanthenes in 59 studies
Studies (neo-gambogic acid) | Trials (neo-gambogic acid) | Recent Studies (post-2010) (neo-gambogic acid) | Studies (xanthenes) | Trials (xanthenes) | Recent Studies (post-2010) (xanthenes) |
---|---|---|---|---|---|
63 | 0 | 59 | 5,020 | 92 | 1,325 |
Protein | Taxonomy | neo-gambogic acid (IC50) | xanthenes (IC50) |
---|---|---|---|
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 7.42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.69) | 18.7374 |
1990's | 1 (1.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 42 (71.19) | 24.3611 |
2020's | 15 (25.42) | 2.80 |
Authors | Studies |
---|---|
Huang, QS; Lu, GB; Yang, XX | 1 |
Asano, J; Chiba, K; Tada, M; Yoshii, T | 1 |
Cheng, H; Fang, N; Li, Q; Peng, D; Su, J; Wang, M; Wang, X; Xia, L; Xu, Q; Yang, L; Zhou, A; Zhu, G | 1 |
Chen, H; Li, Q; Su, J; Wang, F; Wang, M; Wang, X; Xia, L; Yan, F | 1 |
Ji, O; Lu, B; Shen, Q; Sun, M; Tang, Y; Wang, K; Zhu, H | 1 |
Cheng, H; Li, Q; Wang, M; Yang, L | 1 |
Chen, HB; Huang, L; Li, QL; Mei, L; Shi, XJ; Wang, XS; Zhou, LZ | 1 |
Cheng, H; Li, QL; Peng, JY; Su, JJ; Wang, M; Wang, XC; Wang, XS; Yan, FG | 1 |
Chang, HC; Cheng, H; Li, J; Li, Q; Li, X; Su, J; Wang, M; Wang, X; Wu, H; Xia, L; Yan, F | 1 |
Gao, J; Han, QB; Ma, L; Wen, ZS; Yu, XJ; Zhou, GB | 1 |
Guan, SH; Guo, DA; Tao, SJ; Wang, Y; Zhang, X | 1 |
Chen, WD; Chen, YJ; Huang, X; Li, QL; Peng, DY; Wang, DL; Wang, XS | 1 |
Chen, L; Fan, Y; He, S; Nie, C; Peng, A; Shao, X | 1 |
Bin, L; Cheng, P; Dong, C; Fenggen, Y; Guanghui, W; Hui, C; Jingjing, S; Mei, W; Meiling, S; Qinglin, L; Xiaoshan, W; Yawen, H; Zhiwu, C | 1 |
Lu, BB; Luo, YH; Tian, Y; Wang, JR; Wang, KM; Zhou, J | 1 |
Chen, JP; Wang, CY; Wang, DL; Wang, SS; Yang, LL | 1 |
Chang, HC; Cheng, H; Hu, Y; Li, Q; Su, J; Wang, M; Xie, C; Zhang, D | 1 |
Cheng, H; Li, QL; Wang, XC; Zhu, GQ | 1 |
Cheng, H; Li, QL; Su, JJ; Zhang, X | 1 |
Dong, L; Hua, X; Liang, C; Qu, X; Zhao, T | 1 |
Cheng, H; Li, QL; Tan, YJ; Zhang, X | 1 |
Ding, J; He, Y; Hu, X; Li, J; Lin, Y; Shi, Y; Wang, J; Wang, K; Zhu, Y | 1 |
Chen, W; Ge, T; Ji, Z; Jia, B; Lin, T; Luo, Q; Peng, D; Wang, L; Zhang, CY; Zhu, T | 1 |
Chen, W; Chen, Y; Li, X; Liang, Y; Liu, L; Pan, W; Wang, X; Yuan, H; Zhang, C | 1 |
Chen, F; Hu, XD; Liu, PD; Lou, ZC; Xie, LH; Zhang, HQ; Zhang, W; Zhang, XH | 1 |
Chen, JP; Chen, YJ; Huang, HP; Huang, P; Wang, CY; Wang, DL; Wang, SJ; Wang, SS; Yang, LL | 1 |
Fan, C; Han, Q; Liu, Y; Wu, X; Xie, Q; Xu, C; Yu, X; Zhang, H; Zhang, X; Zhao, Q | 1 |
Chao, J; Chen, B; Cheng, Y; Han, B; Liu, H; Wang, Z; Yao, H; Zhang, M; Zhang, W; Zhou, Z | 1 |
Chen, W; Cheng, H; Huang, X; Lin, T; Luo, Q; Peng, D; Wang, X; Wang, Y; Zhou, K; Zhu, T | 1 |
Wang, XB; Yu, XJ; Zhang, JX; Zhao, Q | 1 |
Cao, W; Chen, W; Han, Z; Liu, Y; Mao, L; Qin, X; Wan, L; Wang, S; Wang, X; Wei, W; Wu, X; Xiao, M; Xu, Q; Yan, M; Ye, D; Zhang, C; Zhang, J; Zhang, Z | 1 |
Fu, W; Lao, Y; Li, X; Meng, X; Qian, J; Tan, H; Tu, S; Xu, H; Xu, L; Xu, N; Zhang, L; Zhou, Q | 1 |
Jia, DD; Jin, G; Li, T; Shen, Y; Wang, FF; Xu, HC | 1 |
Chen, W; Ge, T; Peng, D; Sun, J; Tang, X; Xu, Q | 1 |
Chen, W; Ge, T; Gui, Q; Sun, J; Tang, X; Zhang, K; Zhang, S | 1 |
Shi, YR; Yang, Y | 1 |
Chen, BA; Sun, R; Zhang, HM | 1 |
Cong, JZ; Hou, JF; Li, XM; Liu, JW; Liu, SJ; Tong, L; Zhang, Y | 1 |
Chen, W; Guo, J; Xu, Q | 1 |
Cheng, H; Hu, RF; Li, QL; Su, JJ; Wang, YL | 1 |
Huang, T; Jia, J; Wang, X; Xu, L; Zhang, H; Zhu, X | 1 |
Chen, W; Peng, D; Sheng, C; Wang, F; Wang, H; Wu, Y; Ye, X | 1 |
Chen, SX; Chen, WD; Ding, BJ; Lin, TY; Tao, YS; Xie, JL; Xun, Y; Yang, YQ; Zhang, XM; Zhu, TT | 1 |
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C | 1 |
Cai, H; Chen, X; Gu, W; Kang, J; Lei, H; Wang, W; Wu, YL; Xu, H; Yang, W; Yin, T; Zhang, X; Zhu, Q | 1 |
Liu, C; Niu, H; Shen, D; Wang, Y | 1 |
Chang, JL; Chen, WD; Ding, BJ; Lin, TY; Peng, W; Xun, Y; Yang, W; Zhao, Y | 1 |
Wang, J; Zhao, N; Zhou, S | 1 |
Cheng, H; Li, Q; Li, S; Su, J; Wang, M; Wang, Y | 1 |
Bi, Y; Guo, J; Liu, Y; Pan, L; Tan, Y; Yu, X; Zhao, Q; Zhong, J | 1 |
Gong, YF; Huang, TY; Huang, XY; Liu, XC; Wang, ZZ; Zhang, XM | 1 |
Bao, Y; Chen, W; Dong, Q; Liu, Y; Wang, B; Yuan, T; Zha, L; Zhang, C | 1 |
Ding, Z; Jing, F; Li, Y; Lu, B; Song, X; Tang, Z; Wu, H | 1 |
Bäck, V; de Thonel, A; Mezger, V; Pesonen, L; Roos-Mattjus, P; Sabéran-Djoneidi, D; Svartsjö, S | 1 |
Cheng, H; Li, Q; Wang, M; Zhan, F | 1 |
Gong, Y; Gu, Y; Li, Y; Lu, Y; Wang, H; Wu, M | 1 |
Fu, P; Guo, F; Hu, Y; Ma, L; Ren, Q; Tao, S; Wu, C; Yang, L | 1 |
Cheng, H; Li, B; Li, Q; Li, S; Liu, C; Luo, S; Su, J; Wang, M; Wu, H | 1 |
Chen, W; Pang, M; Peng, D; Sun, J; Tang, X; Xu, Q | 1 |
1 review(s) available for neo-gambogic acid and xanthenes
Article | Year |
---|---|
Anticancer activity and underlying mechanism of neogambogic acid.
Topics: Animals; Antineoplastic Agents, Phytogenic; Garcinia; Humans; Neoplasms; Plant Extracts; Xanthenes | 2018 |
58 other study(ies) available for neo-gambogic acid and xanthenes
Article | Year |
---|---|
[Isolation and structure of neo-gambogic acid from Gamboge (Garcinia hanburryi)].
Topics: Antineoplastic Agents, Phytogenic; Benzopyrans; Chemical Phenomena; Chemistry; Plants, Medicinal; Xanthenes | 1984 |
Cytotoxic xanthones from Garcinia hanburyi.
Topics: Cell Line; Cell Survival; Humans; Magnetic Resonance Spectroscopy; Plants, Medicinal; Spectrometry, Mass, Fast Atom Bombardment; Terpenes; Xanthenes; Xanthones | 1996 |
Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Female; Garcinia; Gene Expression Regulation; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Resins, Plant; RNA, Messenger; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2010 |
Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Humans; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oncogene Protein v-akt; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Terpenes; Tumor Cells, Cultured; Xanthenes; Xanthones | 2011 |
The mechanism of neogambogic acid-induced apoptosis in human MCF-7 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Fas Ligand Protein; fas Receptor; Female; G1 Phase; Garcinia; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Resting Phase, Cell Cycle; Terpenes; Xanthenes; Xanthones | 2011 |
[Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Terpenes; Vascular Endothelial Growth Factor A; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2011 |
Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; ErbB Receptors; Garcinia; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Terpenes; Time Factors; Xanthenes; Xanthones | 2012 |
Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Garcinia; Humans; Imidazoles; Mice; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Pyridines; Terpenes; Up-Regulation; Xanthenes; Xanthones | 2011 |
Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Cell Shape; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Terpenes; Time Factors; Xanthenes; Xanthones | 2012 |
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Terpenes; TOR Serine-Threonine Kinases; Xanthenes; Xanthones | 2012 |
Biotransformation of gambogenic acid by Chaetomium globosum CICC 2445.
Topics: Antineoplastic Agents, Phytogenic; Chaetomium; HeLa Cells; Humans; Molecular Structure; Terpenes; Xanthenes; Xanthones | 2012 |
Solid lipid nanoparticles as delivery systems for Gambogenic acid.
Topics: Animals; Calorimetry, Differential Scanning; Freeze Drying; Lipids; Nanoparticles; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Terpenes; Xanthenes; Xanthones | 2013 |
Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelium, Vascular; Female; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Plant Extracts; Plants, Medicinal; Proto-Oncogene Proteins c-akt; rho GTP-Binding Proteins; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xanthenes; Xanthones; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
Gambogenic acid kills lung cancer cells through aberrant autophagy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Lysosomes; Male; Membrane Proteins; Mice; Phagosomes; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2014 |
Gambogenic acid induction of apoptosis in a breast cancer cell line.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Caspases; Cell Proliferation; Female; Flow Cytometry; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Terpenes; Tumor Cells, Cultured; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2013 |
Ultra-high-performance liquid chromatography tandem mass spectrometry method for the determination of gambogenic acid in dog plasma and its application to a pharmacokinetic study.
Topics: Administration, Intravenous; Animals; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Linear Models; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Xanthenes | 2014 |
Synergistic effects of 5-fluorouracil and gambogenic acid on A549 cells: activation of cell death caused by apoptotic and necroptotic mechanisms via the ROS-mitochondria pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Fluorouracil; Humans; Mitochondria; Necrosis; Reactive Oxygen Species; Xanthenes | 2014 |
[Gambogenic acid induces mitochondria-dependent apoptosis in human gastric carcinoma cell line].
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Garcinia; Humans; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms; Tumor Suppressor Protein p53; Xanthenes | 2014 |
[Study of gambogenic acid-induced apoptosis of melanoma B16 cells through PI3K/Akt/mTOR signaling pathways].
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Melanoma; Mice; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Terpenes; TOR Serine-Threonine Kinases; Xanthenes; Xanthones | 2014 |
Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MS.
Topics: Animals; Chromatography, High Pressure Liquid; Garcinia; Male; Plant Extracts; Plasma; Rats; Rats, Wistar; Tandem Mass Spectrometry; Xanthenes; Xanthones | 2015 |
[Apoptosis of melanoma B16 cells induced by gambogenic acid].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Garcinia; Melanoma, Experimental; Mice; Mitochondria; Reactive Oxygen Species; Terpenes; Xanthenes | 2014 |
Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin.
Topics: Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Xanthenes | 2015 |
A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Topics: Cell Culture Techniques; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Colloids; Drug Delivery Systems; Drug Liberation; Endocytosis; Glycerides; Liquid Crystals; Nanoparticles; Particle Size; Polyethylenes; Polypropylenes; Xanthenes | 2015 |
Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Topics: Animals; Biological Availability; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Drug Stability; Excipients; Female; Freeze Drying; Half-Life; Hep G2 Cells; Humans; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Polyvinyls; Rats; Rats, Sprague-Dawley; Solubility; Solvents; Surface-Active Agents; Suspensions; Xanthenes | 2016 |
Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells.
Topics: Amines; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Cerium; Female; G2 Phase; Humans; MCF-7 Cells; Metal Nanoparticles; Radiation-Sensitizing Agents; Reactive Oxygen Species; Xanthenes | 2015 |
Preparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Gambogenic Acid.
Topics: Cytotoxins; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Nanoparticles; Xanthenes | 2015 |
Gambogenic acid inhibits LPS-simulated inflammatory response by suppressing NF-κB and MAPK in macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cytokines; Drugs, Chinese Herbal; Humans; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Xanthenes | 2016 |
Neogambogic acid prevents silica-induced fibrosis via inhibition of high-mobility group box 1 and MCP-1-induced protein 1.
Topics: Animals; Cell Line; HMGB1 Protein; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Ribonucleases; Silicon Dioxide; Xanthenes | 2016 |
Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic.
Topics: Drug Compounding; Drug Delivery Systems; Lipids; Nanostructures; Xanthenes | 2017 |
Gambogenic acid induces proteasomal degradation of CIP2A and sensitizes hepatocellular carcinoma to anticancer agents.
Topics: Antineoplastic Agents; Autoantigens; Carcinoma, Hepatocellular; Cell Proliferation; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Proteins; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; Ubiquitination; Xanthenes | 2016 |
A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Humans; Proteolysis; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitination; Xanthenes | 2017 |
Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Receptors, Fibroblast Growth Factor; Signal Transduction; Tumor Burden; Xanthenes; Xenograft Model Antitumor Assays | 2018 |
Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cathepsin K; Cell Differentiation; Cell Proliferation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Monocytes; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; RANK Ligand; Receptors, Calcitonin; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Transcriptome; Xanthenes | 2018 |
Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.
Topics: Animals; Bupropion; Chlorzoxazone; Constitutive Androstane Receptor; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inducers; Dose-Response Relationship, Drug; Drug Interactions; Liver; Male; Phenacetin; Rats; Receptors, Cytoplasmic and Nuclear; Xanthenes | 2018 |
PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Liposomes; Mice, Inbred C57BL; Polyethylene Glycols; Rabbits; Rats, Sprague-Dawley; Staining and Labeling; Xanthenes | 2018 |
[Mechanism Research of Gambogenic Acid on Proliferation,Apoptosis and Invasion of Cervical Carcinoma He La Cells].
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Proliferation; Down-Regulation; Female; HeLa Cells; Humans; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Up-Regulation; Uterine Cervical Neoplasms; Xanthenes | 2016 |
Preparation of Neogambogic Acid Nanoliposomes and its Pharmacokinetics in Rats.
Topics: Animals; Drug Compounding; Liposomes; Male; Rats; Rats, Wistar; Xanthenes | 2018 |
Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.
Topics: Adenosine Triphosphatases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; NF-kappa B; Rhodamine 123; Xanthenes | 2019 |
[Mechanism of gambogenic acid in resisting angiogenesis of lung cancer in vitro].
Topics: A549 Cells; Apoptosis; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Transfection; Xanthenes | 2018 |
Gambogenic acid inhibits the proliferation of small‑cell lung cancer cells by arresting the cell cycle and inducing apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Garcinia; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Small Cell Lung Carcinoma; Xanthenes; Xenograft Model Antitumor Assays | 2019 |
Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
Topics: Animals; Female; Immunoglobulin M; Injections; Liposomes; Liver; Male; Metabolic Clearance Rate; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Spleen; Xanthenes | 2019 |
A novel drug delivery system of mixed micelles based on poly(ethylene glycol)-poly(lactide) and poly(ethylene glycol)-poly(ɛ-caprolactone) for gambogenic acid.
Topics: Drug Delivery Systems; Hep G2 Cells; Humans; Micelles; Polyesters; Polyethylene Glycols; Xanthenes | 2019 |
Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Topics: Animals; Biological Availability; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Half-Life; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Xanthenes; Zein | 2019 |
Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Deubiquitinating Enzymes; Garcinia; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Osteosarcoma; Signal Transduction; SOXB1 Transcription Factors; Ubiquitin Thiolesterase; Ubiquitination; Xanthenes | 2020 |
Gambogenic acid exerts anticancer effects in cisplatin‑resistant non‑small cell lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; G1 Phase; Humans; Lung Neoplasms; Neoplasm Proteins; Xanthenes | 2020 |
Folic acid-modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation.
Topics: A549 Cells; Animals; Apoptosis; Drug Liberation; Endocytosis; Folic Acid; Humans; Liposomes; Particle Size; Rats, Sprague-Dawley; Static Electricity; Surface-Active Agents; Tissue Distribution; Xanthenes | 2020 |
Gambogenic acid suppresses bladder cancer cells growth and metastasis by regulating NF-κB signaling.
Topics: Cell Line, Tumor; Cell Proliferation; Humans; Neoplasm Metastasis; NF-kappa B; Signal Transduction; Urinary Bladder Neoplasms; Xanthenes | 2020 |
Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
Topics: Cell Line, Tumor; Cell Survival; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Ferroptosis; Humans; Melanoma; Skin Neoplasms; Xanthenes | 2020 |
Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Xanthenes; Xenograft Model Antitumor Assays | 2020 |
Scar-reducing effects of gambogenic acid on skin wounds in rabbit ears.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cicatrix, Hypertrophic; Collagen; Cytokines; Disease Models, Animal; Ear; Female; Inflammation Mediators; Male; Neovascularization, Physiologic; Rabbits; Signal Transduction; Skin; Wound Healing; Wounds and Injuries; Xanthenes | 2021 |
Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Drug Carriers; Folic Acid; Humans; Indoles; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Xanthenes | 2021 |
Role of gambogenic acid in regulating PI3K/Akt/NF-kβ signaling pathways in rat model of acute hepatotoxicity.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Liver; Male; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Xanthenes | 2021 |
Gambogic acid and gambogenic acid induce a thiol-dependent heat shock response and disrupt the interaction between HSP90 and HSF1 or HSF2.
Topics: Cell Line, Tumor; CRISPR-Cas Systems; Heat Shock Transcription Factors; Heat-Shock Proteins; Heat-Shock Response; HSP90 Heat-Shock Proteins; Humans; Protein Binding; Sulfhydryl Compounds; Transcription Factors; Xanthenes; Xanthones | 2021 |
Gambogenic Acid Inhibits Basal Autophagy of Drug-Resistant Hepatoma Cells and Improves Its Sensitivity to Adriamycin.
Topics: Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Humans; Xanthenes | 2022 |
Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt/β-catenin pathway.
Topics: Apoptosis; beta Catenin; Calcium-Binding Proteins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Glycogen Synthase Kinase 3 beta; Humans; Membrane Proteins; Neoplastic Stem Cells; Proliferating Cell Nuclear Antigen; Wnt Signaling Pathway; Xanthenes | 2022 |
Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism.
Topics: Animals; Biological Products; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Fibronectins; Fibrosis; Folic Acid; Histones; Kidney; Kidney Diseases; Mice; RNA, Small Interfering; Transforming Growth Factor beta1; Ureteral Obstruction; Xanthenes; Xanthones | 2022 |
Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma.
Topics: Animals; Autophagy; Cell Proliferation; Ferroptosis; Melanoma; Mice; Mice, Inbred C57BL; MicroRNAs; RNA, Long Noncoding; Xanthenes | 2022 |
Anti-tumor Effect of Gambogenic Acid and Its Effect on CYP2C and CYP3A after Oral Administration.
Topics: Administration, Oral; Animals; Cytochrome P-450 CYP3A; Mice; Mice, Nude; Neoplasms; Rats; RNA, Messenger; Xanthenes | 2023 |